{"id":"https://openalex.org/W7204687488","doi":"https://doi.org/10.1016/s2152-2650(26)02965-4","title":"MM-953: Safety, Tolerability, and Clinical Activity of Anitocabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma","display_name":"MM-953: Safety, Tolerability, and Clinical Activity of Anitocabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204687488","doi":"https://doi.org/10.1016/s2152-2650(26)02965-4"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)02965-4","doi":"https://doi.org/10.1016/s2152-2650(26)02965-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02965-4","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104136477","display_name":"Pranati Dharmesh Shah","orcid":"https://orcid.org/0009-0003-0331-892X","observed_orcids":["https://orcid.org/0009-0003-0331-892X"]},"institutions":[{"id":"https://openalex.org/I26347476","display_name":"Loma Linda University","ror":"https://ror.org/04bj28v14","country_code":"US","type":"education","lineage":["https://openalex.org/I26347476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pranati Shah","raw_affiliation_strings":["Loma Linda University, Loma Linda, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Loma Linda University, Loma Linda, CA, USA","institution_ids":["https://openalex.org/I26347476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074185514","display_name":"Nasim Salimiaghdam","orcid":"https://orcid.org/0000-0003-0431-4704","observed_orcids":["https://orcid.org/0000-0003-0431-4704"]},"institutions":[{"id":"https://openalex.org/I4210158932","display_name":"Capital Health","ror":"https://ror.org/04nyjea81","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210158932"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nasim Salimiaghdam","raw_affiliation_strings":["Capital Health Group, Trenton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Capital Health Group, Trenton, NJ, USA","institution_ids":["https://openalex.org/I4210158932"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133393397","display_name":"Karina Basmajian","orcid":"https://orcid.org/0009-0008-7024-0428","observed_orcids":["https://orcid.org/0009-0008-7024-0428"]},"institutions":[{"id":"https://openalex.org/I2799587377","display_name":"Arrowhead Regional Medical Center","ror":"https://ror.org/00yvh2s32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799587377"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karina Basmajian","raw_affiliation_strings":["Arrowhead Medical Center, Colton, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arrowhead Medical Center, Colton, CA, USA","institution_ids":["https://openalex.org/I2799587377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122809527","display_name":"Milan Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Milan Patel","raw_affiliation_strings":["Creighton University, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Creighton University, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148677939","display_name":"Jeffrey Hu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Hu","raw_affiliation_strings":["Creighton University, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Creighton University, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136096668","display_name":"Kyle Nguyen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyle Nguyen","raw_affiliation_strings":["Creighton University, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Creighton University, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110337134","display_name":"Mojtaba Akhtari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26347476","display_name":"Loma Linda University","ror":"https://ror.org/04bj28v14","country_code":"US","type":"education","lineage":["https://openalex.org/I26347476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mojtaba Akhtari","raw_affiliation_strings":["Loma Linda University, Loma Linda, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Loma Linda University, Loma Linda, CA, USA","institution_ids":["https://openalex.org/I26347476"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S1133","last_page":"S1134"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.7900000214576721,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.7900000214576721,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.20229999721050262,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/b-cell-maturation-antigen","display_name":"BCMA","score":0.6899999976158142},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.6710000038146973},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/autologous-t-cells","display_name":"autologous T cells","score":0.7599999904632568},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.9039999842643738},{"id":"https://openalex.org/keywords/immune-effector-cell-associated-neurotoxicity-syndrome","display_name":"immune effector cell-associated neurotoxicity syndrome","score":0.9520000219345093},{"id":"https://openalex.org/keywords/minimal-residual-disease-negativity","display_name":"minimal residual disease negativity","score":0.8349999785423279},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.875},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7770000100135803},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.6259999871253967},{"id":"https://openalex.org/keywords/fludarabine-and-cyclophosphamide","display_name":"fludarabine and cyclophosphamide","score":0.8529999852180481}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9757000207901001},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.8234000205993652},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44020000100135803},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40689998865127563},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4018999934196472},{"id":"https://openalex.org/C188758523","wikidata":"https://www.wikidata.org/wiki/Q6947334","display_name":"Myeloma protein","level":3,"score":0.28380000591278076},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.21580000221729279},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2117999941110611},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2003999948501587},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.186599999666214}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)02965-4","doi":"https://doi.org/10.1016/s2152-2650(26)02965-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02965-4","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4405044091","https://openalex.org/W4417002574","https://openalex.org/W4405039439","https://openalex.org/W4401876369","https://openalex.org/W7214072331","https://openalex.org/W4310159091","https://openalex.org/W3196553875","https://openalex.org/W3213772166","https://openalex.org/W4307027657","https://openalex.org/W3212441345"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-08-31T00:00:00"}